These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IN-VITRO DECARBOXYLATION OF NEW PHENYLALANINE DERIVATIVES. FERRINI R, GLAESSER A. Biochem Pharmacol; 1964 May; 13():798-801. PubMed ID: 14181284 [No Abstract] [Full Text] [Related]
3. In vitro inhibition of dopa decarboxylase by 6-alkyl derivatives of 3-(3,4-dihydroxyphenyl)alanine (dopa). Morgenstern AP, Nauta WT. Arzneimittelforschung; 1972 Oct; 22(10):1766-8. PubMed ID: 4677070 [No Abstract] [Full Text] [Related]
4. CATECHOLAMINES, BIOSYNTHESIS AND INHIBITORS OF FORMATION. WEISS B, ROSSI GV. Am J Pharm Sci Support Public Health; 1963 Jun; 135():206-18. PubMed ID: 14046042 [No Abstract] [Full Text] [Related]
5. DOPA DECARBOXYLASE ACTIVITY IN THE SKIN. MOELLER H. Acta Derm Venereol; 1963 Jun; 43():485-90. PubMed ID: 14061560 [No Abstract] [Full Text] [Related]
6. Substrate specificity and other properties of DOPA decarboxylase from guinea pig kidneys. Srinivasan K, Awapara J. Biochim Biophys Acta; 1978 Oct 12; 526(2):597-604. PubMed ID: 309771 [Abstract] [Full Text] [Related]
7. Effect of analogs of phenylalanine and tryptophan on kinetics of DOPA decarboxylase in rat brain. De Ropp RS, Furst A. Brain Res; 1966 Oct 12; 2(4):323-32. PubMed ID: 5298124 [No Abstract] [Full Text] [Related]
8. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin. Yamabe H, Lovenberg W. Biochem Biophys Res Commun; 1972 May 26; 47(4):733-9. PubMed ID: 5063594 [No Abstract] [Full Text] [Related]
10. The syntheses and substrate specificity for mammalian dihydroxyphenylalanine decarboxylase of 3-, 4-, 5-, and 6-methyl-2-hydroxyphenylalanines and the substrate specificity of 3-, 5-, and 6-methyl-2,4-dihydroxyphenylalanines for the enzyme. Bower RH, Lambooy JP. J Med Chem; 1969 Nov 26; 12(6):1028-30. PubMed ID: 5351443 [No Abstract] [Full Text] [Related]
11. INCREASE IN ACCUMULATION OF L-DOPA (3,4-DIHYDROXY-PHENYLALANINE) IN BRAIN SLICES BY ALCOHOL. KANIIKE K, YOSHIDA H. Jpn J Pharmacol; 1963 Dec 26; 13():292-6. PubMed ID: 14097560 [No Abstract] [Full Text] [Related]
12. Improved ionization chamber method for continuous measurement of DOPA decarboxylase activity. Tran N. Anal Biochem; 1972 Jul 26; 48(1):112-9. PubMed ID: 5041398 [No Abstract] [Full Text] [Related]
13. DOPA decarboxylase activity in a transplantable hamster melanoma. Håkanson R, Möller H, Stormby NG. Experientia; 1965 May 15; 21(5):265-6. PubMed ID: 5841256 [No Abstract] [Full Text] [Related]
14. METABOLISM OF DOPA-14C IN THE NORMAL AND ALPHA-METHYLDOPATREATED MOUSE. WEISS B, ROSSI GV. Biochem Pharmacol; 1963 Dec 15; 12():1399-405. PubMed ID: 14096427 [No Abstract] [Full Text] [Related]
15. MULTIPLE INHIBITORY EFFECTS OF ALPHA-METHYLAMINO ACIDS ON THE METABOLISM OF C14-LABELED TYROSINE, DOPA AND ALPHA-METHYLDOPA. MORAN JF, SOURKES TL. J Pharmacol Exp Ther; 1965 May 15; 148():252-61. PubMed ID: 14301016 [No Abstract] [Full Text] [Related]
16. [DOPA-DOPP-transaminases of rat brain in vitro]. Gey KF. Helv Physiol Pharmacol Acta; 1967 May 15; 25(2):CR187-9. PubMed ID: 5588161 [No Abstract] [Full Text] [Related]
17. ON FORMATION OF NORADRENALINE IN THE SKIN: ACTIVITY OF DOPAMINE-BETA-OXIDASE. MOELLER H. Acta Derm Venereol; 1963 May 15; 43():548-51. PubMed ID: 14088645 [No Abstract] [Full Text] [Related]
18. Effects of pyridoxal phosphate and L-dopapyridoxal phosphate on DOPA decarboxylase activity. Tran N. Experientia; 1972 Sep 15; 28(9):1021-2. PubMed ID: 4665286 [No Abstract] [Full Text] [Related]
19. EFFECT OF SOME BENZYLHYDRAZINES AND BENZYLOXYAMINES ON DOPA AND 5-HYDROXYTRYPTOPHAN DECARBOXYLASE IN VIVO. HANSSON E, FLEMING RM, CLARK WG. Int J Neuropharmacol; 1964 May 15; 3():177-88. PubMed ID: 14336525 [No Abstract] [Full Text] [Related]